In a major development, Merck and Ridgeback’s investigational oral antiviral Molnupiravir for the treatment of mild-to-moderate Covid-19 is likely to get approval “within days.”
The...
The Phase Three vaccination strategy beginning from May 1 has been announced. Importantly, it states that there would be no walk-in registrations for people...
Union Health Minister Harsh Vardhan on Wednesday inaugurated the DME-fired Aditi Urja Sanch unit along with the DME-LPG blended fuel cylinders and opened them...
